| Literature DB >> 29878481 |
Veronika Ecker1, Charles Knoery2, Gordon Rushworth2,3, Ian Rudd2, Astrid Ortner1, David Begley4, Stephen J Leslie2,5.
Abstract
Atrial fibrillation is the most common heart-rhythm disorder, affecting about 1.5% to 2% of the population with an increased risk of mortality and morbidity due to stroke, thromboembolism, and heart failure. If the conversion back to sinus rhythm does not happen spontaneously, pharmacological or electrical cardioversion (ECV) is the next available treatment options for some patients. However, the long-term success following ECV is variable. This review describes the factors that are associated with maintenance of sinus rhythm following ECV and proposes a clinical strategy based on the available evidence.Entities:
Keywords: Atrial Fibrillation; Electrical Cardioversion; Sinus Rhythm
Mesh:
Substances:
Year: 2018 PMID: 29878481 PMCID: PMC6489932 DOI: 10.1002/clc.22931
Source DB: PubMed Journal: Clin Cardiol ISSN: 0160-9289 Impact factor: 2.882